"Um, Nenhum, Cem Mil" - Uma breve compreensão do narcisismo em Green através de um personagem literário de Pirandello e de um caso clínico / "One, None and a Hundred Thousand" - A brief discussion of narcissism in Green through a Pirandello personage and a clinical case

Cada vez mais encontramos, na clínica psicoterápica, pacientes com uma intensa precariedade de seus limites psíquicos e com uma dificuldade de representações simbólicas que parecem ir além do amor pela própria imagem. Tem-se a impressão de estar diante de um cenário de falha na constituição narcísica do ego: uma angústia frente a imagem que não se enxerga porque existem apenas fragmentos, ainda não existe uma unidade. O presente artigo pretende apresentar aspectos do tratamento psicoterápico da clínica do narcisismo através da discussão de fragmentos do livro "Um, nenhum, cem mil" de Luigi Pirandello, de uma breve revisão sobre o trabalho do negativo em André Green e da ilustração de um caso clínico.(AU)

Increasingly we find, in the psychotherapeutic clinic, patients with an intense precariousness of their psychic limits and with a difficulty in symbolic representations that seem to go beyond the love of their own image. One has the impression of facing a scenario of failure in the narcissistic constitution of the ego: an anguish before the image that can not be seen because there are only fragments, there is still no unity. This article intends to present aspects of the psychotherapeutic treatment of the narcissism clinic through the discussion of fragments of Luigi Pirandello's book "One, No One and One Hundred Thousand", a brief review of the work of the negative in André Green and the illustration of a clinical case study.(AU)

Drug interactions between antineoplastic and antidepressant agents: analysis of patients seen at an oncology clinic at a general hospital.

OBJECTIVES: To determine the prevalence of depressive symptoms among oncology patients and identify simultaneous use of antineoplastic and antidepressant agents. METHODS: This was a cross-sectional study that interviewed 56 oncology patients using two data collection instruments: a questionnaire covering clinical and sociodemographic data and the Beck Depression Inventory-II (BDI-II), for assessment of depressive symptoms. For data analysis, descriptive statistics were used to determine the prevalence of depressive symptoms and the chi-square test was used to evaluate associations between sociodemographic and clinical variables and depressive symptoms. RESULTS: A 26.7% (15 patients) prevalence of depression was detected. Just eight of these 15 patients (53.3%) were receiving treatment for depression. In the sample as a whole, 13 of the patients interviewed (23.2%) were taking antidepressants and 11 of these 13 patients (19.6%) were taking antidepressive and antineoplastic agents simultaneously. A total of five (8.9% of the sample) contraindicated drug interactions were detected. CONCLUSIONS: Depressive symptoms are more prevalent among cancer patients than in the general population, but they are generally under-diagnosed and under-treated. Simultaneous use of antidepressant and antineoplastic agents is common and so, in order to reduce the number of harmful adverse effects, possible drug interactions must be identified before antidepressants are prescribed to cancer patients.

Drug interactions between antineoplastic and antidepressant agents: analysis of patients seen at an oncology clinic at a general hospital / Interação medicamentosa entre antineoplásicos e antidepressivos: análise de pacientes do ambulatório de oncologia de um hospital geral

Objectives: To determine the prevalence of depressive symptoms among oncology patients and identify simultaneous use of antineoplastic and antidepressant agents. Methods: This was a cross-sectional study that interviewed 56 oncology patients using two data collection instruments: a questionnaire covering clinical and sociodemographic data and the Beck Depression Inventory-II (BDI-II), for assessment of depressive symptoms. For data analysis, descriptive statistics were used to determine the prevalence of depressive symptoms and the chi-square test was used to evaluate associations between sociodemographic and clinical variables and depressive symptoms. Results: A 26.7% (15 patients) prevalence of depression was detected. Just eight of these 15 patients (53.3%) were receiving treatment for depression. In the sample as a whole, 13 of the patients interviewed (23.2%) were taking antidepressants and 11 of these 13 patients (19.6%) were taking antidepressive and antineoplastic agents simultaneously. A total of five (8.9% of the sample) contraindicated drug interactions were detected. Conclusions: Depressive symptoms are more prevalent among cancer patients than in the general population, but they are generally under-diagnosed and under-treated. Simultaneous use of antidepressant and antineoplastic agents is common and so, in order to reduce the number of harmful adverse effects, possible drug interactions must be identified before antidepressants are prescribed to cancer patients. .

Objetivos: Verificar a prevalência de sintomas depressivos em pacientes oncológicos e identificar o uso simultâneo de antineoplásicos e antidepressivos. Métodos: Foi realizado um estudo transversal, no qual 56 pacientes oncológicos foram entrevistados. Foram empregados dois instrumentos: um questionário para a coleta de dados clínicos e sociodemográficos e o Inventário de Depressão de Beck - Segunda Edição (BDI-II) para a avaliação de sintomas depressivos. Para a análise dos dados, foram utilizadas medidas descritivas para determinar a prevalência de sintomas depressivos, o teste de qui-quadrado para avaliar associações entre variáveis sociodemográficas e clínicas e sintomas depressivos. Resultados: Foi encontrada uma prevalência de depressão de 26,7% (15 pacientes). Apenas oito desses pacientes (53,3%) estavam recebendo tratamento para depressão. Considerando a amostra como um todo, estavam fazendo uso de antidepressivos 13 pacientes (23,2%); destes, 11 faziam uso simultâneo de antidepressivo e antineoplásico (19,6%). Foram encontradas cinco situações de interações medicamentosas contraindicadas (8,9%). Conclusão: Sintomas depressivos são mais prevalentes em pacientes oncológicos do que na população em geral, mas geralmente são subdiagnosticados e subtratados. O uso simultâneo de antidepressivos e antineoplásicos é frequente. Sendo assim, para reduzir os efeitos adversos prejudiciais, as possíveis interações medicamentosas devem ser identificadas antes que os antidepressivos sejam prescritos para pacientes oncológicos. .